At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,767 enrolled
Drug / intervention
Nucleic acid amplification test 1 for NG and CT +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Performance of Nucleic Acid Amplification Tests for the Detection of Neisseria Gonorrhoeae and Chlamydia Trachomatis in Extragenital Sites
In Brief
A clinical study evaluating Nucleic acid amplification test 1 for NG and CT, Nucleic acid amplification test 2 for NG and CT, and 1 other intervention for Neisseria Gonorrhoeae Infection and 2 related conditions. Completed, enrolled 2,767 participants across 9 sites.
Detailed Summary
The purpose of this study was to use participant samples to simultaneously evaluate three nucleic acid amplification tests (NAATs) diagnostic platforms.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeisseria Gonorrhoeae Infection, Chlamydia Trachomatis Infection, Sexually Transmitted Infections
CountriesUnited States
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 2016
Enrollment StartApr 2017
Primary CompletionMar 2018
TodayJul 2026
First PostedAug 17, 2016
Enrollment StartApr 10, 2017
Primary CompletionMar 12, 2018
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 9.9 years ago
Interventions
Nucleic acid amplification test 1 for NG and CTother
A combination test using real-time PCR to detect DNA from NG and CT.
Nucleic acid amplification test 2 for NG and CTother
A combination test using target amplification to detect RNA from NG and CT.
Nucleic acid amplification test 3 for NG and CTother
A combination test using real-time PCR to detect DNA from NG and CT.